CareDx (CDNA) Quick Ratio: History & Chart

CareDx, Inc(CDNA)

Medical - Diagnostics & Research · Brisbane, CA

$65.76-4.09 (-5.86%)

Delayed quote: Oct 6, 2026, 2:20 PM EDT

About CareDx, Inc

CareDx, Inc. is a global innovator specializing in the discovery, development, and commercialization of diagnostic and management tools designed for transplant recipients and their healthcare providers. The company's extensive portfolio features a range of specialized diagnostic solutions for organ monitoring, including: AlloSure Kidney, AlloSure Heart, and AlloSure Lung: Advanced tests employing donor-derived cell-free DNA (dd-cfDNA) technology to assess the health of kidney, heart, and lung transplants, respectively. AlloMap Heart: A gene expression-based solution specifically for heart transplant patients. AlloSeq cfDNA: A broader surveillance tool to measure dd-cfDNA levels in the blood. CareDx also provides cutting-edge human leukocyte antigen (HLA) typing technologies, such as TruSight HLA, an NGS-based high-resolution typing solution; Olerup SSP, which uses sequence-specific primer technology for HLA allele typing; QTYPE for precise HLA typing; and AlloSeq Tx, another high-resolution HLA typing offering. For stem cell transplant recipients, the company offers AlloSeq HCT for chimerism testing. Beyond diagnostics, CareDx develops vital software and digital platforms to streamline transplant patient management. These include Ottr, a dedicated transplant patient management software; XynQAPI, focused on transplant quality tracking and waitlist management; and AlloCare, a mobile application serving as a patient-centric resource for those who have undergone transplantation. The company distributes its products directly to clients, as well as through a network of third-party distributors and sub-distributors. CareDx has forged significant partnerships, including a licensing agreement with Illumina, Inc. for the distribution, development, and commercialization of next-generation sequencing (NGS) products and technologies. Additionally, it collaborates with Cibiltech SAS to commercialize iBox, a software designed for the predictive analysis of kidney allograft loss post-transplantation. Founded in 1998, the company was initially known as XDx, Inc. before rebranding to CareDx, Inc. in March 2014. Its headquarters are located in South San Francisco, California.

Brisbane, CA

763 employees

www.caredx.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: John Walter Hanna Jr.

View full financials

CDNA Quick Ratio (Acid-Test) Metrics

QUICK RATIO (ACID-TEST)

4.51

QUICK RATIO (ACID-TEST) AVG TTM

3.18

QUICK RATIO (ACID-TEST) AVG 3Y

3.70

QUICK RATIO (ACID-TEST) AVG 5Y

4.27

QUICK RATIO (ACID-TEST) AVG 10Y

3.28

QUICK RATIO (ACID-TEST) AVG 15Y

N/A

QUICK RATIO (ACID-TEST) AVG 20Y

N/A

CURRENT VS TTM AVG

+41.84%

CURRENT VS 3Y AVG

+21.93%

CURRENT VS 5Y AVG

+5.59%

CURRENT VS 10Y AVG

+37.60%

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

3.35

median of 871 covered companies

CURRENT VS SECTOR MEDIAN

+34.52%

vs the sector median at left

NAME	MARKET CAP	QUICK RATIO (ACID-TEST)	TTM	3Y	5Y
CareDx, Inc (CDNA)	$3.40B	4.51	3.18	3.70	4.27
Acadia Pharmaceuticals Inc. (ACAD)vs ›	$3.39B	3.30	3.01	3.08	4.22
Pulse Biosciences, Inc. (PLSE)vs ›	$3.44B	9.61	11.20	9.88	7.68
Parabilis Medicines, Inc. (PBLS)vs ›	$3.34B	17.91	1.68	1.68	1.68
Viking Therapeutics, Inc. (VKTX)vs ›	$3.34B	4.72	21.21	17.30	19.05
IDEAYA Biosciences, Inc. (IDYA)vs ›	$3.48B	10.45	13.16	14.41	11.78
Celcuity Inc. (CELC)vs ›	$3.50B	8.93	9.13	14.29	16.91
Xenon Pharmaceuticals Inc. (XENE)vs ›	$3.50B	21.02	15.64	20.34	22.11
Tango Therapeutics, Inc. (TNGX)vs ›	$3.51B	50.82	11.65	9.40	9.07
iRhythm Technologies, Inc. (IRTC)vs ›	$3.56B	3.75	5.09	3.82	4.05

NAME

MARKET CAP

QUICK RATIO (ACID-TEST)

TTM

CareDx, Inc (CDNA)

$3.40B

4.51

3.18

3.70

4.27

Acadia Pharmaceuticals Inc. (ACAD)vs ›

$3.39B

3.30

3.01

3.08

4.22

Pulse Biosciences, Inc. (PLSE)vs ›

$3.44B

9.61

11.20

9.88

7.68

Parabilis Medicines, Inc. (PBLS)vs ›

$3.34B

17.91

1.68

Viking Therapeutics, Inc. (VKTX)vs ›

$3.34B

4.72

21.21

17.30

19.05

IDEAYA Biosciences, Inc. (IDYA)vs ›

$3.48B

10.45

13.16

14.41

11.78

Celcuity Inc. (CELC)vs ›

$3.50B

8.93

9.13

14.29

16.91

Xenon Pharmaceuticals Inc. (XENE)vs ›

$3.50B

21.02

15.64

20.34

22.11

Tango Therapeutics, Inc. (TNGX)vs ›

$3.51B

50.82

11.65

9.40

9.07

iRhythm Technologies, Inc. (IRTC)vs ›

$3.56B

3.75

5.09

3.82

4.05

Quick Ratio (Acid-Test) FAQ

What is the quick ratio (acid-test) for CareDx, Inc (CDNA)?

The quick ratio (acid-test) for CDNA stock is 4.51.

Is CareDx, Inc's quick ratio (acid-test) high or low?

The quick ratio (acid-test) of 4.51 is in line with its 5-year average of 4.27, around the middle of its 5-year range (2.56–7.57).

What is the TTM average quick ratio (acid-test) for CareDx, Inc (CDNA)?

The TTM average quick ratio (acid-test) for CDNA stock is 3.18.

What is the 3Y average quick ratio (acid-test) for CareDx, Inc (CDNA)?

The 3Y average quick ratio (acid-test) for CDNA stock is 3.70.

What is the 5Y average quick ratio (acid-test) for CareDx, Inc (CDNA)?

The 5Y average quick ratio (acid-test) for CDNA stock is 4.27.

What is the 10Y average quick ratio (acid-test) for CareDx, Inc (CDNA)?

The 10Y average quick ratio (acid-test) for CDNA stock is 3.28.

DATE	QUICK RATIO (ACID-TEST)
2026-06-30	4.51
2026-03-31	3.07
2025-12-31	2.56
2025-09-30	2.75
2025-06-30	3.00
2025-03-31	3.84
2024-12-31	3.72
2024-09-30	3.87
2024-06-30	3.85
2024-03-31	4.03
2023-12-31	3.77
2023-09-30	4.50
2023-06-30	4.59
2023-03-31	4.92
2022-12-31	4.85
2022-09-30	5.27
2022-06-30	4.91
2022-03-31	5.88
2021-12-31	5.38
2021-09-30	6.11
2021-06-30	7.57
2021-03-31	9.29
2020-12-31	3.80
2020-09-30	3.98
2020-06-30	4.26
2020-03-31	2.09
2019-12-31	1.89
2019-09-30	2.01
2019-06-30	2.20
2019-03-31	4.42
2018-12-31	3.91
2018-09-30	2.36
2018-06-30	1.83
2018-03-31	2.06
2017-12-31	0.49
2017-09-30	0.35
2017-06-30	0.25
2017-03-31	0.32
2016-12-31	0.52
2016-09-30	0.70
2016-06-30	0.63
2016-03-31	1.90
2015-12-31	3.31
2015-09-30	3.55
2015-06-30	4.77
2015-03-31	6.62
2014-12-31	3.56
2014-09-30	3.73
2014-06-30	0.61
2014-03-31	0.83
2013-12-31	1.01
2013-09-30	0.00
2013-06-30	0.00
2013-03-31	0.00

DATE

QUICK RATIO (ACID-TEST)

2026-06-30

4.51

2026-03-31

3.07

2025-12-31

2.56

2025-09-30

2.75

2025-06-30

3.00

2025-03-31

3.84

2024-12-31

3.72

2024-09-30

3.87

2024-06-30

3.85

2024-03-31

4.03

2023-12-31

3.77

2023-09-30

4.50

2023-06-30

4.59

2023-03-31

4.92

2022-12-31

4.85

2022-09-30

5.27

2022-06-30

4.91

2022-03-31

5.88

2021-12-31

5.38

2021-09-30

6.11

2021-06-30

7.57

2021-03-31

9.29

2020-12-31

3.80

2020-09-30

3.98

2020-06-30

4.26

2020-03-31

2.09

2019-12-31

1.89

2019-09-30

2.01

2019-06-30

2.20

2019-03-31

4.42

2018-12-31

3.91

2018-09-30

2.36

2018-06-30

1.83

2018-03-31

2.06

2017-12-31

0.49

2017-09-30

0.35

2017-06-30

0.25

2017-03-31

0.32

2016-12-31

0.52

2016-09-30

0.70

2016-06-30

0.63

2016-03-31

1.90

2015-12-31

3.31

2015-09-30

3.55

2015-06-30

4.77

2015-03-31

6.62

2014-12-31

3.56

2014-09-30

3.73

2014-06-30

0.61

2014-03-31

0.83

2013-12-31

1.01

2013-09-30

0.00

2013-06-30

0.00

2013-03-31

0.00

Quick Ratio (Acid-Test): 4.51

CDNA Quick Ratio

CDNA Average Quick Ratio (Acid-Test) Chart

CDNA Current vs Average Quick Ratio (Acid-Test) Chart

CDNA Quick Ratio (Acid-Test) Metrics

CDNA Competitors' Quick Ratio (Acid-Test)

Liquidity Comparison

Quick Ratio (Acid-Test) Formula & Definition

Quick Ratio (Acid-Test) FAQ

CDNA Quick Ratio (Acid-Test) History

Related Metrics